Consolidated Planning Corp Johnson & Johnson Transaction History

Consolidated Planning Corp

$549 Million
Q2 2024

A detailed history of Consolidated Planning Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Consolidated Planning Corp holds 6,110 shares of JNJ stock, worth $1.02 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,110

Previous 29,502 79.29%

Holding current value

$1.02 Million

Previous $4.67 Million 80.86%

% of portfolio

0.16%

Previous 0.85%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$144.38 - $157.78 $3.38 Million - $3.69 Million	-23,392 Reduced 79.29%	6,110 $893,000
Q1 2024 May 02, 2024	BUY	$155.22 - $162.74 $66,744 - $69,978	430 Added 1.48%	29,502 $4.67 Million
Q4 2023 Feb 02, 2024	SELL	$145.6 - $158.88 $154,772 - $168,889	-1,063 Reduced 3.53%	29,072 $4.56 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $31,773 - $35,593	-204 Reduced 0.67%	30,135 $4.69 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $810,028 - $871,745	5,248 Added 20.92%	30,339 $5.02 Million
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $902,674 - $1.08 Million	5,976 Added 31.26%	25,091 $3.89 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $2.41 Million - $2.71 Million	15,048 Added 370.0%	19,115 $3.38 Million
Q3 2022 Nov 04, 2022	SELL	$161.33 - $179.52 $34,524 - $38,417	-214 Reduced 5.0%	4,067 $664,000
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $35,488 - $39,248	211 Added 5.18%	4,281 $760,000
Q1 2022 May 03, 2022	SELL	$158.14 - $179.59 $13,600 - $15,444	-86 Reduced 2.07%	4,070 $721,000
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $12,474 - $13,840	-80 Reduced 1.89%	4,156 $711,000
Q3 2021 Nov 17, 2021	BUY	$161.5 - $179.47 $13,404 - $14,896	83 Added 2.0%	4,236 $684,000
Q2 2021 Jul 26, 2021	SELL	$159.48 - $171.07 $12,758 - $13,685	-80 Reduced 1.89%	4,153 $684,000
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $34,134 - $38,017	223 Added 5.56%	4,233 $695,000
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $21,663 - $24,866	158 Added 4.1%	4,010 $631,000
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $7,580 - $8,306	-54 Reduced 1.38%	3,852 $573,000
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $257 - $311	2 Added 0.05%	3,906 $549,000
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $111 - $153	1 Added 0.03%	3,904 $512,000
Q4 2019 Apr 29, 2020	BUY	$127.5 - $146.44 $497,632 - $571,555	3,903 New	3,903 $569,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.

Account

Consolidated Planning Corp Johnson & Johnson Transaction History